Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2206 | 2323 | 37.5 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
209 | 2 | EXPERIMENTAL HEMATOLOGY//THROMBOPOIETIN//HEMATOLOGY | 20851 |
2206 | 1 | G CSF//GM CSF//GRANULOCYTE COLONY STIMULATING FACTOR | 2323 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | G CSF | authKW | 206771 | 7% | 9% | 166 |
2 | GM CSF | authKW | 191569 | 7% | 9% | 163 |
3 | GRANULOCYTE COLONY STIMULATING FACTOR | authKW | 175599 | 6% | 9% | 142 |
4 | COLONY STIMULATING FACTORS | authKW | 138321 | 3% | 15% | 68 |
5 | PIXY321 | authKW | 135573 | 1% | 74% | 14 |
6 | RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | authKW | 79505 | 0% | 55% | 11 |
7 | GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | authKW | 78035 | 3% | 8% | 73 |
8 | INTERLEUKIN 3 | authKW | 69728 | 2% | 11% | 49 |
9 | HEMATOPOIETIC GROWTH FACTORS | authKW | 62985 | 2% | 13% | 38 |
10 | MOLGRAMOSTIM | authKW | 56069 | 0% | 53% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 27643 | 33% | 0% | 776 |
2 | Oncology | 4188 | 23% | 0% | 541 |
3 | Immunology | 2911 | 18% | 0% | 425 |
4 | Medicine, Research & Experimental | 1251 | 10% | 0% | 225 |
5 | Transplantation | 640 | 4% | 0% | 89 |
6 | Critical Care Medicine | 270 | 2% | 0% | 57 |
7 | Cell Biology | 245 | 7% | 0% | 170 |
8 | Infectious Diseases | 216 | 4% | 0% | 85 |
9 | Cell & Tissue Engineering | 201 | 1% | 0% | 22 |
10 | Medicine, General & Internal | 181 | 6% | 0% | 135 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN VISCERAL THORAX VASC SURG | 52572 | 0% | 100% | 4 |
2 | 133 NAKAMICHI | 13143 | 0% | 100% | 1 |
3 | 300 SHERBOURNE ST | 13143 | 0% | 100% | 1 |
4 | ABT KFO | 13143 | 0% | 100% | 1 |
5 | ANALYT DEV TEAM | 13143 | 0% | 100% | 1 |
6 | ASSAY TECHNOL TOSHIMA KU | 13143 | 0% | 100% | 1 |
7 | BIOCHEM 11 HANKOU RD | 13143 | 0% | 100% | 1 |
8 | BIOL THER Y SECT BIOL THER Y SOLID TUMORS | 13143 | 0% | 100% | 1 |
9 | CANC EXPTL THER EUT PROGRAM | 13143 | 0% | 100% | 1 |
10 | CELLULAR THER Y MINATO KU | 13143 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL HEMATOLOGY | 18979 | 4% | 2% | 91 |
2 | BLOOD | 16234 | 9% | 1% | 207 |
3 | INTERNATIONAL JOURNAL OF CELL CLONING | 16051 | 1% | 5% | 23 |
4 | BRITISH JOURNAL OF HAEMATOLOGY | 4816 | 3% | 1% | 71 |
5 | BONE MARROW TRANSPLANTATION | 4117 | 2% | 1% | 53 |
6 | LYMPHOKINE AND CYTOKINE RESEARCH | 3564 | 0% | 3% | 8 |
7 | SEMINARS IN HEMATOLOGY | 3016 | 1% | 1% | 21 |
8 | EUROPEAN JOURNAL OF HAEMATOLOGY | 2111 | 1% | 1% | 25 |
9 | INTERNATIONAL REVIEW OF EXPERIMENTAL PATHOLOGY | 1976 | 0% | 4% | 4 |
10 | BLOOD CELLS | 1954 | 0% | 2% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HARTUNG, T , (1999) IMMUNOMODULATION BY COLONY-STIMULATING FACTORS.REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY 136. VOL. 136. ISSUE . P. 1 -164 | 261 | 48% | 25 |
2 | GRANT, SM , HEEL, RC , (1992) RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RGM-CSF) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND PROSPECTIVE ROLE IN THE MANAGEMENT OF MYELOSUPPRESSION.DRUGS. VOL. 43. ISSUE 4. P. 516-560 | 166 | 62% | 43 |
3 | HARMENBERG, J , HOGLUND, M , HELLSTROMLINDBERG, E , (1994) G-CSF AND GM-CSF IN ONCOLOGY AND ONCOLOGICAL HEMATOLOGY.EUROPEAN JOURNAL OF HAEMATOLOGY. VOL. 52. ISSUE . P. 1-28 | 140 | 63% | 25 |
4 | FLEISCHMAN, RA , (1993) SOUTHWESTERN INTERNAL-MEDICINE CONFERENCE - CLINICAL USE OF HEMATOPOIETIC GROWTH-FACTORS.AMERICAN JOURNAL OF THE MEDICAL SCIENCES. VOL. 305. ISSUE 4. P. 248-273 | 150 | 57% | 17 |
5 | DEMETRI, GD , GRIFFIN, JD , (1991) GRANULOCYTE COLONY-STIMULATING FACTOR AND ITS RECEPTOR.BLOOD. VOL. 78. ISSUE 11. P. 2791-2808 | 87 | 54% | 769 |
6 | GASSON, JC , (1991) MOLECULAR PHYSIOLOGY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.BLOOD. VOL. 77. ISSUE 6. P. 1131-1145 | 102 | 51% | 581 |
7 | SPIEKERMANN, K , ROESLER, J , EMMENDOERFFER, A , ELSNER, J , WELTE, K , (1997) FUNCTIONAL FEATURES OF NEUTROPHILS INDUCED BY G-CSF AND GM-CSF TREATMENT: DIFFERENTIAL EFFECTS AND CLINICAL IMPLICATIONS.LEUKEMIA. VOL. 11. ISSUE 4. P. 466-478 | 91 | 64% | 62 |
8 | LIESCHKE, GJ , BURGESS, AW , (1992) DRUG-THERAPY - GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR .1..NEW ENGLAND JOURNAL OF MEDICINE. VOL. 327. ISSUE 1. P. 28-35 | 52 | 83% | 585 |
9 | MOORE, MAS , (1991) THE CLINICAL USE OF COLONY STIMULATING FACTORS.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 9. ISSUE . P. 159-191 | 81 | 81% | 85 |
10 | HARTUNG, T , VON AULOCK, S , WENDEL, A , (1998) ROLE OF GRANULOCYTE COLONY-STIMULATING FACTOR IN INFECTION AND INFLAMMATION.MEDICAL MICROBIOLOGY AND IMMUNOLOGY. VOL. 187. ISSUE 2. P. 61-69 | 74 | 73% | 16 |
Classes with closest relation at Level 1 |